Patent · US Expired

5-Hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia

US6121330A · kind A · utility

6Cited by

5References

7Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Matthias Muller-Gliemann · Haan, DE
Rolf Angerbauer · Wuppertal, DE
Arndt Brandes · Wuppertal, DE
Michael Logers · Wuppertal, DE
Carsten Schmeck · Wuppertal, DE
Gunter Schmidt · Houghton, US
Klaus-Dieter Bremm · Recklinghausen, DE
Hilmar Bischoff · Wuppertal, DE
Delf Schmidt · Wuppertal, DE

Key dates

Filing date	Sep 2, 1999
Grant date	Sep 19, 2000
Priority date	—
Expiry date	Sep 2, 2019

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The novel 5-hydroxy-alkyl-substituted phenyls are prepared by either reacting the corresponding benzaldehydes with the Grignard compounds and subsequently reducing the other functional groups or by reducing the corresponding benzoic esters by customary methods to give the corresponding hydroxyl compounds. The 5-hydroxy-alkyl-substituted phenyls are suitable for use as active compounds in medicaments, in particular for the treatment of dyslipidaemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.